[Ovarian hyperstimulation syndrome: pathophysiology and systemic repercussions].
Trillo Urrutia
L
L
Gris Martínez
J M
JM
D058186:Acute Kidney Injury / Q000209:etiology; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001201:Ascites / Q000209:etiology / Q000601:surgery; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology; D003131:Combined Modality Therapy; D005260:Female; D005440:Fluid Therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000503:physiopathology* / Q000628:therapy; D019152:Paracentesis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology / Q000503:physiopathology
D000700:Analgesics; D000925:Anticoagulants; D006063:Chorionic Gonadotropin; D006493:Heparin